Disha Malani - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Disha Malani

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Cancer Discovery|November 18, 2021

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid LeukemiaDisha Malani, Ashwini Kumar, Oscar Brück, et al.

Blood Cancer Discovery|March 5, 2024

Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed MyeloblastsElyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, et al.

Nature Communications|April 21, 2018

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic targetOlli Dufva, Matti Kankainen, Tiina Kelkka, et al.

Nature Communications|October 31, 2024

Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemiaRebekka Wegmann, Ximena Bonilla, Ruben Casanova, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Cancer Discovery|November 18, 2021

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid LeukemiaDisha Malani, Ashwini Kumar, Oscar Brück, et al.

Blood Cancer Discovery|March 5, 2024

Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed MyeloblastsElyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, et al.

Nature Communications|April 21, 2018

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic targetOlli Dufva, Matti Kankainen, Tiina Kelkka, et al.

Nature Communications|October 31, 2024

Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemiaRebekka Wegmann, Ximena Bonilla, Ruben Casanova, et al.

Pageof 2